GSK wins FDA clearance for wider use of Boostrix

12/8/2008 | CNNMoney

The FDA granted approval for the use of GlaxoSmithKline's Boostrix -- a vaccine against tetanus, diphtheria and whooping cough -- in adults ages 19 to 64. The decision expands GSK's market for the vaccine, which is cleared as a booster for patients ages 10 to 18.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC